Estados financieros detallados de Oragenics, Inc. (OGEN): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $0.50, OGEN presenta beneficios negativos (P/E no significativo) y un ROE del -144.23%. La capitalización bursátil es de $2M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $75044 | $65803 | $30110 | $62622 | $22.1M | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$75044 | -$65803 | -$30110 | -$62622 | -$22.1M | 0 | 0 | 0 | 0 | 0 |
| I+D | $4.8M | $3.5M | $6.0M | $12.1M | $22.1M | $10.6M | $10.1M | $15.5M | $4.1M | $2.39B |
| Generales y Administrativos | $3.8M | $3.2M | $4.0M | $3.8M | $4.5M | $5.3M | $4.5M | $5.5M | $6.4M | $6.97B |
| Gastos Operativos | $8.5M | $6.7M | $10.0M | $15.9M | $4.5M | $15.8M | $14.4M | $20.9M | $10.6M | $9.4M |
| Beneficio Operativo | -$8.5M | -$6.7M | -$10.0M | -$15.9M | -$26.6M | -$15.8M | -$14.4M | -$20.9M | -$10.6M | -$9.4M |
| EBITDA | -$8.4M | -$6.4M | -$9.9M | -$15.5M | -$26.6M | -$15.7M | -$14.2M | -$20.6M | -$10.5M | $762.2M |
| Gastos por Intereses | $4116 | $216328 | $5786 | $7300 | $10685 | $15756 | $15103 | $30591 | $29828 | $785930 |
| Beneficio Antes de Impuestos | -$8.5M | -$6.7M | -$9.9M | -$15.6M | -$26.4M | -$15.7M | -$14.3M | -$20.7M | -$10.6M | -$10.0M |
| Impuestos | 0 | $13207 | -$79999 | $7756 | 0 | 0 | 0 | 0 | 0 | -$136910 |
| Beneficio Neto | -$7.0M | -$6.7M | -$9.9M | -$15.6M | -$26.4M | -$15.7M | -$14.3M | -$20.7M | -$10.6M | -$9.8M |
| BPA | $-94.35 | $-81.99 | $-45.62 | $-22.10 | $-28.05 | $-8.09 | $-7.11 | $-9.18 | $-1.60 | $-4.56 |
| BPA Diluido | $-94.33 | $-81.99 | $-45.62 | $-22.10 | $-28.05 | $-8.09 | $-7.11 | $-9.18 | $-1.60 | $-4.56 |
| Acciones en Circulación (Diluidas) | $74348 | $82104 | $217318 | $704732 | $942187 | $1.9M | $2.0M | $2.2M | $6.6M | $2.2M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $4.1M | $6.2M | $20.2M | $18.3M | $17.6M | $27.3M | $11.4M | $3.5M | $864840 | $4.4M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $4.0M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | $6987 | 0 | 0 | 0 | $53082 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $4.2M | $7.2M | $21.9M | $18.8M | $18.0M | $27.7M | $14.3M | $3.9M | $1.5M | $10.1M |
| Inmovilizado Material | $87462 | $21659 | $116276 | $914652 | $697851 | $523590 | $468502 | $9811 | 0 | 0 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $4.3M | $7.2M | $22.0M | $19.8M | $18.7M | $28.2M | $14.8M | $5.0M | $1.5M | $10.1M |
| Cuentas por Pagar | $461344 | $618360 | $828706 | $1.2M | $330379 | $854983 | $246690 | $1.2M | $1.1M | $1.6M |
| Deuda a Corto | $66377 | $80478 | $124213 | $143864 | $228227 | $303416 | $267640 | $312703 | $328528 | $227348 |
| Pasivos Corrientes | $1.3M | $898522 | $1.2M | $1.9M | $1.3M | $1.4M | $1.6M | $1.8M | $1.7M | $1.8M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.3M | $898522 | $1.2M | $2.5M | $1.8M | $1.7M | $1.7M | $1.8M | $1.7M | $1.8M |
| Reservas | -$94.7M | -$101.4M | -$111.4M | -$127.4M | -$154.4M | -$171.3M | -$185.6M | -$206.2M | -$216.8M | -$226.6M |
| Patrimonio Neto | $3.0M | $6.3M | $20.9M | $17.2M | $16.8M | $26.5M | $13.0M | $3.2M | -$211885 | $8.3M |
| Deuda Total | $66377 | $80478 | $124213 | $979650 | $898917 | $797206 | $624526 | $322514 | $328528 | $227348 |
| Deuda Neta | -$4.0M | -$6.1M | -$20.1M | -$17.3M | -$16.7M | -$26.5M | -$10.8M | -$3.2M | -$536312 | -$8.2M |
| Capital Circulante | $2.9M | $6.3M | $20.8M | $17.0M | $16.6M | $26.3M | $12.7M | $2.1M | -$211885 | $8.3M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$7.0M | -$6.7M | -$9.9M | -$15.6M | -$26.4M | -$15.7M | -$14.3M | -$20.7M | -$10.6M | -$9.84B |
| Amortizaciones | $75044 | $65803 | $30110 | $62622 | $51705 | $41237 | $44667 | $27391 | 0 | $771.4M |
| Compensación en Acciones | $638418 | $560478 | $1.0M | $552997 | $1.5M | $1.7M | $742203 | $1.0M | $516049 | $642.4M |
| Cambio en Capital Circulante | $675375 | -$188119 | -$228144 | $1.9M | $37019 | $512143 | -$1.7M | $2.0M | $1.5M | -$857224 |
| Flujo de Caja Operativo | -$7.1M | -$6.4M | -$9.1M | -$13.0M | -$17.0M | -$13.5M | -$15.2M | -$7.3M | -$8.6M | -$9.25B |
| Inversiones (CapEx) | -$27179 | 0 | -$124727 | -$25214 | 0 | -$43876 | -$127519 | -$1.0M | 0 | -$3 |
| Adquisiciones | $1.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | -$5.6M | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | -$58670 | 0 | 0 | -$1.1M | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$7.1M | -$6.4M | -$9.2M | -$13.0M | -$17.0M | -$13.5M | -$15.4M | -$8.3M | -$8.6M | -$9.25B |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Beneficio Neto (anual) | +4.0% | -47.3% | -57.1% | -69.7% | +40.6% | +9.1% | -44.6% | +48.8% | +6.9% | |
| Crecimiento BPA (anual) | +13.1% | +44.4% | +51.6% | -26.9% | +71.2% | +12.1% | -29.1% | +82.6% | -185.0% | |
| Cambio en Acciones (anual) | +10.4% | +164.7% | +224.3% | +33.7% | +99.7% | +6.7% | +12.0% | +194.3% | -67.4% | |
| Crecimiento FCF (anual) | +10.4% | -44.6% | -41.6% | -30.0% | +20.3% | -13.6% | +46.0% | -3.7% | -107448.9% | |
| Tasa Impositiva Efectiva | -0.0% | -0.2% | 0.8% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | 1.4% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-95.53 | $-77.51 | $-42.36 | $-18.50 | $-17.99 | $-7.18 | $-7.64 | $-3.68 | $-1.30 | $-4286.54 |
| Dividendo por Acción | $0.00 | $0.00 | $0.27 | $0.00 | $0.00 | $0.59 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $74333 | $82104 | $217318 | $704732 | $942187 | $1.9M | $2.0M | $2.2M | $6.6M | $2.2M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -144.23% |
| Rentabilidad sobre capital invertido | -279.54% |
| Rentabilidad sobre activos | -183.59% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 3.01 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -103.02 | -51.57 | -33.89 | -42.60 | -28.81 | -99.23 | -26.61 | -18.40 | -6.92 | -0.17 |
| P/VC | 243.62 | 54.96 | 16.09 | 38.50 | 45.21 | 57.04 | 29.21 | 119.95 | -346.28 | 0.20 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Empresas relacionadas: AIM · CANF · CNSP · ENSC · KALA · KZIA · QLGN
Explorar sector: Healthcare · Biotechnology
Más secciones de OGEN: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones